Oscar Health, Inc.
OSCR
$13.23
$0.231.77%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.67B | 11.26B | 10.71B | 10.06B | 9.16B |
| Total Other Revenue | 28.59M | 24.44M | 20.54M | 19.27M | 20.58M |
| Total Revenue | 11.70B | 11.29B | 10.73B | 10.08B | 9.18B |
| Cost of Revenue | 10.02B | 9.46B | 8.88B | 8.04B | 7.33B |
| Gross Profit | 1.68B | 1.82B | 1.84B | 2.04B | 1.84B |
| SG&A Expenses | 2.05B | 2.00B | 1.94B | 1.84B | 1.76B |
| Depreciation & Amortization | 28.89M | 30.25M | 30.43M | 31.06M | 32.15M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.10B | 11.50B | 10.86B | 9.91B | 9.12B |
| Operating Income | -396.36M | -210.34M | -129.47M | 168.83M | 57.27M |
| Income Before Tax | -437.30M | -238.31M | -151.33M | 143.16M | 33.43M |
| Income Tax Expenses | 5.61M | 5.45M | 9.33M | 19.01M | 7.31M |
| Earnings from Continuing Operations | -442.90 | -243.75 | -160.66 | 124.15 | 26.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -248.00K | -333.00K | -575.00K | -810.00K | -689.00K |
| Net Income | -443.15M | -244.09M | -161.23M | 123.34M | 25.43M |
| EBIT | -396.36M | -210.34M | -129.47M | 168.83M | 57.27M |
| EBITDA | -367.47M | -180.10M | -99.03M | 199.89M | 89.41M |
| EPS Basic | -1.57 | -0.95 | -0.64 | 0.49 | 0.16 |
| Normalized Basic EPS | -0.97 | -0.58 | -0.38 | 0.35 | 0.12 |
| EPS Diluted | -1.76 | -1.19 | -0.88 | 0.21 | -0.08 |
| Normalized Diluted EPS | -1.10 | -0.71 | -0.51 | 0.19 | -0.02 |
| Average Basic Shares Outstanding | 1.05B | 1.01B | 998.13M | 981.27M | 961.43M |
| Average Diluted Shares Outstanding | 1.10B | 1.07B | 1.05B | 1.10B | 1.09B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |